Somatostatin Receptor Subtype-4 Agonist NNC 26-9100 Mitigates the Effect of Soluble Aβ42 Oligomers via a Metalloproteinase-Dependent Mechanism

Brain Research - Netherlands
doi 10.1016/j.brainres.2013.05.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Chronic Peripheral Administration of Somatostatin Receptor Subtype-4 Agonist NNC 26-9100 Enhances Learning and Memory in SAMP8 Mice

European Journal of Pharmacology
Pharmacology
2011English

The Muscarinic Acetylcholine Receptor Agonist BuTAC Mediates Antipsychotic-Like Effects via the M4 Subtype

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2013English

Early Cerebral Activities of the Environmental Estrogen Bisphenol a Appear to Act via the Somatostatin Receptor Subtype Sst2

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2002English

Somatostatin Receptor 4 (SSTR4)

Science-Business eXchange
2009English

Design of Donecopride, a Dual Serotonin Subtype 4 Receptor Agonist/Acetylcholinesterase Inhibitor With Potential Interest for Alzheimer's Disease Treatment

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Metabotropic Glutamate Receptor Subtype 4 (mGluR4)

Science-Business eXchange
2010English

Somatostatin Receptor Subtype Expression in Cells of the Rat Immune System During Adjuvant Arthritis

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
1999English

Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2016English

CNS Progenitor Cells Promote a Permissive Environment for Neurite Outgrowth via a Matrix Metalloproteinase-2-Dependent Mechanism

Journal of Neuroscience
Neuroscience
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy